ArticleCell death discovery2023

AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects.

Meher Bolisetti Gayatri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.